A detailed history of American National Bank transactions in Bio N Tech Se stock. As of the latest transaction made, American National Bank holds 880 shares of BNTX stock, worth $106,233. This represents 0.01% of its overall portfolio holdings.

Number of Shares
880
Previous 880 -0.0%
Holding current value
$106,233
Previous $70,000 48.57%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 10, 2024

BUY
$88.96 - $112.35 $78,284 - $98,868
880 New
880 $81,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $29.3B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track American National Bank Portfolio

Follow American National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American National Bank, based on Form 13F filings with the SEC.

News

Stay updated on American National Bank with notifications on news.